Search results

Results 1 – 20 of 1,225
Advanced search

Search in namespaces:

There is a page named "Serotonin-norepinephrine releasing agent" on Wikipedia

View (previous 20 | ) (20 | 50 | 100 | 250 | 500)
  • A serotonin releasing agent (SRA) is a type of drug that induces the release of serotonin into the neuronal synaptic cleft. A selective serotonin releasing...
    7 KB (773 words) - 23:34, 2 September 2023
  • Thumbnail for Norepinephrine releasing agent
    A norepinephrine releasing agent (NRA), also known as an adrenergic releasing agent, is a catecholaminergic type of drug that induces the release of norepinephrine...
    4 KB (384 words) - 05:53, 31 August 2024
  • serotoninnorepinephrine–dopamine releasing agent (SNDRA), also known as a triple releasing agent (TRA), is a type of drug which induces the release of...
    4 KB (391 words) - 09:29, 23 May 2023
  • Thumbnail for Serotonin–norepinephrine releasing agent
    A serotoninnorepinephrine releasing agent (SNRA) is a type of drug which induces the release of serotonin and norepinephrine (and epinephrine) in the...
    1 KB (126 words) - 21:20, 2 September 2024
  • A norepinephrine–dopamine releasing agent (NDRA) is a type of drug which induces the release of norepinephrine (and epinephrine) and dopamine in the body...
    1 KB (74 words) - 20:50, 8 August 2021
  • Thumbnail for Monoamine releasing agent
    Serotonin–norepinephrine releasing agent (SNRA) Serotonin–dopamine releasing agent (SDRA) Serotoninnorepinephrine–dopamine releasing agent (SNDRA) MRAs must...
    68 KB (5,482 words) - 04:43, 29 September 2024
  • Thumbnail for Serotonin–norepinephrine reuptake inhibitor
    Serotoninnorepinephrine reuptake inhibitors (SNRIs) are a class of antidepressant medications used to treat major depressive disorder (MDD), anxiety disorders...
    79 KB (7,725 words) - 03:02, 24 September 2024
  • many releasing agents of both dopamine and norepinephrine (norepinephrine–dopamine releasing agents or NDRAs) and of serotonin, norepinephrine, and dopamine...
    11 KB (1,258 words) - 07:45, 10 August 2024
  • a releasing agent of serotonin and dopamine. Monoamine releasing agent Serotonin releasing agent Dopamine releasing agent Serotoninnorepinephrine–dopamine...
    3 KB (340 words) - 02:16, 6 September 2024
  • Thumbnail for Norepinephrine–dopamine reuptake inhibitor
    neurotransmission. A closely related type of drug is a norepinephrine–dopamine releasing agent (NDRA). Many NDRIs exist, including the following: Amineptine...
    6 KB (418 words) - 04:31, 25 July 2024
  • Thumbnail for Norepinephrine reuptake inhibitor
    related type of drug is a norepinephrine releasing agent (NRA). Many NRIs exist, including the following: Selective norepinephrine reuptake inhibitors Marketed...
    7 KB (630 words) - 08:12, 26 September 2024
  • Thumbnail for Fenfluramine
    Fenfluramine (category Serotonin-norepinephrine releasing agents)
    a norepinephrine–dopamine releasing agent acting primarily on norepinephrine, results in a well-balanced serotoninnorepinephrine releasing agent with...
    36 KB (3,106 words) - 01:35, 6 September 2024
  • A serotoninnorepinephrine–dopamine reuptake inhibitor (SNDRI), also known as a triple reuptake inhibitor (TRI), is a type of drug that acts as a combined...
    128 KB (15,244 words) - 05:38, 25 July 2024
  • Thumbnail for Serotonin–dopamine reuptake inhibitor
    closely related type of drug is a serotonin–dopamine releasing agent (SDRA). Relative to serotoninnorepinephrine–dopamine reuptake inhibitors (SNDRIs)...
    16 KB (1,821 words) - 01:24, 30 March 2024
  • Thumbnail for Monoamine-depleting agent
    Monoamine-depleting agents are a group of drugs which reversibly deplete one or more of the monoamine neurotransmitters, serotonin, dopamine, and norepinephrine. One...
    3 KB (252 words) - 01:20, 3 September 2024
  • Thumbnail for Serotonin reuptake inhibitor
    dopamine reuptake inhibitors and norepinephrine reuptake inhibitors. SRIs are not synonymous with selective serotonin reuptake inhibitors (SSRIs), as the...
    11 KB (843 words) - 10:04, 13 March 2024
  • Thumbnail for Serotonin
    serotonin mediated release of nitric oxide from endothelial cells, and the inhibition of release of norepinephrine from adrenergic nerves. Serotonin is...
    131 KB (14,080 words) - 08:03, 8 September 2024
  • α-Methyltryptamine [αMT] (Indopan) – non-selective serotonin receptor agonist, serotoninnorepinephrine–dopamine releasing agent (SNDRA), and weak RIMA Etryptamine [α-Ethyltryptamine...
    17 KB (1,478 words) - 23:23, 28 July 2024
  • Thumbnail for 3,4-Methylenedioxyamphetamine
    3,4-Methylenedioxyamphetamine (category Serotonin-norepinephrine-dopamine releasing agents)
    recreational drug. In its pharmacology, MDA is a serotoninnorepinephrine–dopamine releasing agent (SNDRA). In most countries, the drug is a controlled...
    24 KB (2,233 words) - 22:28, 8 September 2024
  • Thumbnail for Α-Ethyltryptamine
    Α-Ethyltryptamine (category Serotonin-norepinephrine-dopamine releasing agents)
    is agranulocytosis. αET acts as a releasing agent of serotonin, norepinephrine, and dopamine, as a weak serotonin receptor agonist, and as a weak monoamine...
    31 KB (2,522 words) - 12:36, 25 September 2024
View (previous 20 | ) (20 | 50 | 100 | 250 | 500)